Amendment to SBIR Phase II Award Contract, effective as of July 1, 2020, by and among Aethlon Medical, Inc., the National Institutes of Health and the National Cancer Institute

EX-10.2 3 atehlon_ex1002.htm MODIFICATION OF CONTRACT

Exhibit 10.2